Scholar Rock (SRRK) Soars 29% as Drug Candidate Progresses

We recently published 10 Market Movers That Made Millionaires in a Week. Scholar Rock Holding Corp. (NASDAQ:SRRK) is one of the best-performing stocks of the past trading week. Scholar Rock saw its share prices climb by 29.2 percent on week-on-week as investors took heart from positive developments for its drug candidate for spinal muscular atrophy (SMA). In an announcement last week, Scholar Rock Holding Corp. (NASDAQ:SRRK) said that it sat down with the Food and Drug Administration and third-party manu ...